RAD BioMed Accelerator

We seek out companies with disruptive new solutions to real-world challenges and unmet needs Come join our strong community of entrepreneurs, benefit from our    in-house, multidisciplinary capabilities and enjoy long-term support Radiaction has received an additional 510(k) Clearance from the Food and Drug Administration (FDA) for its Radiation Shielding System Zsquare has received FDA 510K clearance for our high-performance single-use ENT endoscope

FEMSelect, developer of EnPlace®, a minimally invasive, meshless approach to pelvic floor ligament fixation, completed its US$9M Series B funding The RAD Group is a group of independent companies that develop, manufacture and market solutions for diverse segments of the networking and telecommunications industry The RAD Group has been named "the most fertile ground" for developing Israeli entrepreneurs, having already produced 56 "serial entrepreneurs " The RAD Group has decades of experience in guiding and nurturing startups as they grow towards commercial launch, sales growth and successful exit, (9 Nasdaq IPOs and 10 M&As)

RAD BioMed’s co-founders, Mr Yehuda Zisapel and Prof Nava Zisapel, also co-founded